Hyoscine in labour

EFFECT OF HYOSCINE -N-BUTYLBROMIDE ON THE DURATION OF FIRST STAGE OF LABOUR IN NULLIPAROUS WOMEN ATTENDING OLABISI ONABANJO UNIVERSITY TEACHING HOSPITAL, SAGAMU: A RANDOMIZED CONTROLLED TRIAL

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201808146688942

Enrollment

126

Registered

2018-08-08

Start date

2018-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth

Interventions

Randomised controlled trial

Aqua

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Nulliparity • Singleton foetus at a gestational age between 37- 42 weeks • Cephalic presentation • Spontaneous active phase of labour with cervical dilatation 4cm • Booked Patients

Exclusion criteria

Exclusion criteria: History of allergy to Buscopan • Previous uterine scar • Malpresentation • Twin gestation • Prior prolonged rupture of membrane • Antepartum haemorrhage • Contracted pelvis • Pre-eclampsia and other hypertensive diseases in labour • Other medical conditions.

Design outcomes

Primary

Measure	Time frame
To Determine the duration of first stage (active phase) of labour among parturients administered with Hyoscine-N- Butylbromide (Injection Buscopan) and compare with suitably matched controls administered with placebo.	—

Secondary

Measure	Time frame
To compare the foetal outcome of parturients administered with Hyoscine-N- Butylbromide (Injection Buscopan) and suitably matched controls administered with placebo.	—

Countries

Nigeria

Contacts

Public ContactAdeniyi Akiseku

Senior registrar

niyikepler@yahoo.com2348036103799

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026